Appropriations bill excerpt only — full text needed for civic analysis

What it does

This is a consolidated appropriations bill for fiscal year 2026 that funds federal government operations. The excerpt provided shows only a technical citation amendment on page 1235, striking and replacing language to rename one division as the 'Further Continuing Appropriations Act, 2026.' The full bill text is not available for analysis.

Why we flagged it

The text provided is a single technical amendment to citation language within a consolidated appropriations act. The full bill's character cannot be determined from this excerpt alone.

What the text implies

• Consolidated appropriations bills routinely contain hundreds of riders, policy amendments, and narrow carve-outs unrelated to core funding. This excerpt does not permit detection of such provisions.
• The phrase 'and for other purposes' in the title is standard boilerplate but signals that substantive policy provisions beyond appropriations may be embedded in the full text.
• Without access to the full bill, it is impossible to assess whether funding levels, restrictions, or beneficiaries have changed relative to prior fiscal years.

Section numbers refer to the bill text the analysis read — linked under Primary records below.

Who it affects

The excerpt provided is a single technical amendment to bill citation language and does not reveal the substantive appropriations, restrictions, or policy riders that would determine actual citizen impact. Without the full text, no civic verdict on the bill's overall effect is possible.

Named in the bill

House Committee on Ways and Means, 119th Congress, Further Continuing Appropriations Act, 2026

Where it stands

• Jan 20, 2026 — Introduced · Congress.gov: “Introduced in House”
• Jan 20, 2026 — Referred to House Committee on Ways and Means and House Committee on the Budget · Congress.gov: “Referred to the Committee on Appropriations, and in addition to the Committees on the Budget, and Ways and…”
• Jan 22, 2026 — Passed the House · Congress.gov: “On passage Passed by the Yeas and Nays: 341 - 88 (Roll No. 45).”
• Jan 30, 2026 — Passed both chambers · Congress.gov: “Passed Senate, under the order of 1/30/2026, having achieved 60 votes in the affirmative, with amendments by…”
• Feb 3, 2026 — Signed into law · Congress.gov: “Became Public Law No: 119-75”
• Feb 3, 2026 — Sent to president · Congress.gov: “Presented to President”

Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.

Money around this bill

130 lobbying clients named this bill on 140 disclosure filings across 2 quarters, Mar 2026 to Jun 2026. Those filings disclosed $47,388,305 in lobbying spend. A filing names 8 bills on average, so that figure is what each filing reported, not a share belonging to this bill.

More lobbying clients named this bill than 100% of bills with at least one filing.

Tom Cole, the sponsor, reported $1,675,258 in PAC receipts in the 2026 cycle. $22,750 of that came from 5 PACs tied to these lobbying clients.

• American Medical Association — $5,643,000 on 2 filings
• National Shooting Sports Foundation — $4,270,000 on 2 filings
• Edison Electric Institute — $4,248,610 on 2 filings
• Elevance Health, Inc. — $4,010,000 on 2 filings
• Pharmaceutical Care Management Association — $3,282,990 on 1 filing

Lobbying Disclosure Act filings through Jul 24, 2026. A filing shows who paid to lobby on a bill it names, not what changed.